As of 2024-07-27, the Relative Valuation of Haemonetics Corp (HAE) is 86.28 USD. This relative valuation is based on P/E multiples. With the latest stock price at 91.06 USD, the upside of Haemonetics Corp based on Relative Valuation is -5.2%.
The range of the Relative Valuation is 56.12 - 95.26 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.3x - 37.7x | 35.2x |
| Forward P/E multiples | 23.7x - 31.0x | 29.7x |
| Fair Price | 56.12 - 95.26 | 86.28 |
| Upside | -38.4% - 4.6% | -5.2% |
| Date | P/E |
| 2024-07-26 | 39.40 |
| 2024-07-25 | 39.20 |
| 2024-07-24 | 39.55 |
| 2024-07-23 | 39.62 |
| 2024-07-22 | 39.05 |
| 2024-07-19 | 38.39 |
| 2024-07-18 | 37.46 |
| 2024-07-17 | 39.11 |
| 2024-07-16 | 39.61 |
| 2024-07-15 | 39.03 |
| 2024-07-12 | 39.19 |
| 2024-07-11 | 38.72 |
| 2024-07-10 | 37.68 |
| 2024-07-09 | 36.43 |
| 2024-07-08 | 37.00 |
| 2024-07-05 | 36.76 |
| 2024-07-03 | 36.40 |
| 2024-07-02 | 35.94 |
| 2024-07-01 | 35.79 |
| 2024-06-28 | 35.79 |
| 2024-06-27 | 35.99 |
| 2024-06-26 | 35.90 |
| 2024-06-25 | 36.09 |
| 2024-06-24 | 37.09 |
| 2024-06-21 | 36.86 |
| 2024-06-20 | 36.99 |
| 2024-06-18 | 36.95 |
| 2024-06-17 | 37.03 |
| 2024-06-14 | 36.63 |
| 2024-06-13 | 37.23 |
| 2024-06-12 | 37.18 |
| 2024-06-11 | 36.09 |
| 2024-06-10 | 37.14 |
| 2024-06-07 | 37.04 |
| 2024-06-06 | 37.81 |
| 2024-06-05 | 38.44 |
| 2024-06-04 | 38.04 |
| 2024-06-03 | 36.78 |
| 2024-05-31 | 36.38 |
| 2024-05-30 | 36.62 |
| 2024-05-29 | 37.85 |
| 2024-05-28 | 38.49 |
| 2024-05-24 | 38.22 |
| 2024-05-23 | 38.35 |
| 2024-05-22 | 38.98 |
| 2024-05-21 | 40.32 |
| 2024-05-20 | 41.22 |
| 2024-05-17 | 41.42 |
| 2024-05-16 | 41.02 |
| 2024-05-15 | 41.75 |